Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro
about
Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaquesThe leukocyte-stiffening property of plasma in early acute respiratory distress syndrome (ARDS) revealed by a microfluidic single-cell study: the role of cytokines and protection with antibodiesTick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathwayEnhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage DevelopmentImprovements in endotoxemic syndromes using a disintegrin, rhodostomin, through integrin αvβ3-dependent pathway.Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.Pathology and pathogenesis of severe acute respiratory syndromeThe SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity.Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.SARS-CoV regulates immune function-related gene expression in human monocytic cells.Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines.SARS coronavirus and innate immunity.Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelSpatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques.Characterization of the Transcriptome and Gene Expression of Brain Tissue in Sevenband Grouper (Hyporthodus septemfasciatus) in Response to NNV Infection.Dendritic cells in viral bronchiolitis.CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis.Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use.Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation.Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.SARS-CoV accessory protein 7a directly interacts with human LFA-1
P2860
Q27319889-7975AA77-A688-4102-B6C4-9A547B93F097Q27339653-0035D127-DAE1-4CB4-A417-15F0F8C096CDQ27468806-3E7AA1D4-6078-461E-8518-4C4C076F42A6Q27487400-06D8C153-A3FF-4709-92BB-06D648FB803DQ33393200-FE077889-0AE7-4037-90C1-9F21767E1A69Q33419694-E44B580B-8569-4D57-B08F-103C4152FF39Q33614444-7E100028-6ACD-43A7-9E32-758D9100BE01Q33963961-E52E8FF6-E274-4431-B17C-A43B9CE35D6CQ34003202-5F4AB1E5-FE1D-4B6D-8CE2-512FD79245C9Q34746496-D28FB843-7159-499F-95E9-89DE77609171Q34894092-3308E877-923C-4124-8D79-2C9B3D5DA040Q35487951-BE83D518-60D8-4D61-B6C6-ECC0D1F46401Q36144565-CA663B33-6506-4E13-80A4-2E43FE37D805Q36319181-0B6B0F5D-136F-4722-9DD5-CDD82DCB3475Q36539000-02CB970D-B82F-495A-92CB-93B93EA49650Q36577616-2D8D9ECD-5F6B-4E82-A66D-AB4BA21D6C93Q36972801-0864C00C-967A-4469-9B20-9FD9911E4549Q36989569-7E9020D5-2748-4879-9511-56C143D47C4BQ37628273-4EE8CCB5-0D08-481E-89C0-D2FC06EC4BFEQ37754636-7585B64C-1A8F-40E8-9CC9-77B8120C35ACQ37955129-939B5E96-83C4-4715-8131-D5098131594FQ38223001-A00E2BDE-EB06-40B8-B017-5BC7C4A8299CQ39279748-FB4052A5-F968-4BFA-9AA2-E2999EA6C2BDQ39923630-F9AEDBCA-B4A4-4C71-AB9D-D2BDA3A6E93BQ40168851-2517F999-58FD-42C7-97B6-66DD772777D3Q41943954-2307A95B-4CCF-49F7-9BB6-BEC2687839EDQ57243831-357C3513-0A52-424F-88D9-BFAEA532361F
P2860
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Modeling the early events of s ...... coronavirus infection in vitro
@ast
Modeling the early events of s ...... coronavirus infection in vitro
@en
Modeling the early events of s ...... coronavirus infection in vitro
@nl
type
label
Modeling the early events of s ...... coronavirus infection in vitro
@ast
Modeling the early events of s ...... coronavirus infection in vitro
@en
Modeling the early events of s ...... coronavirus infection in vitro
@nl
prefLabel
Modeling the early events of s ...... coronavirus infection in vitro
@ast
Modeling the early events of s ...... coronavirus infection in vitro
@en
Modeling the early events of s ...... coronavirus infection in vitro
@nl
P2093
P2860
P50
P3181
P1433
P1476
Modeling the early events of s ...... coronavirus infection in vitro
@en
P2093
Cheng-Hsiang Hsiao
Yu-Ting Yen
P2860
P304
P3181
P356
10.1128/JVI.80.6.2684-2693.2006
P407
P577
2006-03-01T00:00:00Z